Ideal Patient
Hypertension (uncontrolled, >160 mmHg systolic): No; Abnormal Renal Function (dialysis, transplant, or creatinine > 200): No; Abnormal Liver Function (bilirubin > 2x ULN, AST/ALT/ALP > 3x ULN): No; Stroke: No; Bleeding History or Predisposition to Bleeding: No; Labile INRs (unstable, high INRs): No; Elderly (age > 65 years): No; Drugs (NSAIDs, antiplatelets): No; Alcohol Abuse: No
Total HAS-BLED Score: 0; Risk Category: Low to Moderate Risk; Estimated Annual Bleeding Risk (%): 1
Hypertension Only
Hypertension (uncontrolled, >160 mmHg systolic): Yes; Abnormal Renal Function (dialysis, transplant, or creatinine > 200): No; Abnormal Liver Function (bilirubin > 2x ULN, AST/ALT/ALP > 3x ULN): No; Stroke: No; Bleeding History or Predisposition to Bleeding: No; Labile INRs (unstable, high INRs): No; Elderly (age > 65 years): No; Drugs (NSAIDs, antiplatelets): No; Alcohol Abuse: No
Total HAS-BLED Score: 1; Risk Category: Low to Moderate Risk; Estimated Annual Bleeding Risk (%): 1.9
Stroke History
Hypertension (uncontrolled, >160 mmHg systolic): No; Abnormal Renal Function (dialysis, transplant, or creatinine > 200): No; Abnormal Liver Function (bilirubin > 2x ULN, AST/ALT/ALP > 3x ULN): No; Stroke: Yes; Bleeding History or Predisposition to Bleeding: No; Labile INRs (unstable, high INRs): No; Elderly (age > 65 years): No; Drugs (NSAIDs, antiplatelets): No; Alcohol Abuse: No
Total HAS-BLED Score: 1; Risk Category: Low to Moderate Risk; Estimated Annual Bleeding Risk (%): 1.9